Article
Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
2022-12-11
Abstract excerpt
<h4>ABSTRACT</h4> Nitric oxide (NO), as a gaseous therapeutic agent, shows great potential for the treatment of many kinds of diseases. Although various NO delivery systems have emerged, the immunogenicity and long-term toxicity of artificial carriers hinder the potential clinical translation of this gas therapeutics. Mesenchymal stem cells (MSCs), with the capacities of self-renewal, differentiation, and low imm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- be2bed77-7958-520b-afef-3dbda9cf2a22
- DOI
- 10.1101/2022.12.11.519950
